Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Major European launch for combined oral contraceptive

May 16, 2002

Roche presents quinoline and quinazoline NPY receptor antagonists

May 15, 2002

Indazoles with thyroid hormone-like activity and their use

May 15, 2002

Ibandronate reduces fracture risk in postmenopausal women on different dosing regimens

May 15, 2002

Antagonists at integrin receptors described for bone disorders, etc.

May 14, 2002

New data on rosiglitazone reported at the ASH meeting

May 14, 2002

Fujisawa reveals new series of potent human Y5 receptor antagonists

May 14, 2002

Inhibitors of 17beta-HSD-2 with utility in osteoporosis, etc.

May 13, 2002

Protein-tyrosine-phosphatase inhibitors with application in type 2 diabetes

May 13, 2002

Hollis-Eden updates progress of HE-2500 and HE-2200

May 13, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...
K2 nabs two Antengene bispecific TCEs in $2B license, option deal
BioWorld
MPM Bioimpact-spawned K2 Therapeutics Inc. inked a license deal plus option agreement, worth $980.5 million apiece, to gain ex-China rights to two of Antengene...